190 related articles for article (PubMed ID: 16391753)
21. Enantioselective Morita-Baylis-Hillman reaction of isatins with acrylates: facile creation of 3-hydroxy-2-oxindoles.
Zhong F; Chen GY; Lu Y
Org Lett; 2011 Jan; 13(1):82-5. PubMed ID: 21138329
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, Cytotoxic Activity on Leukemia Cell Lines and Quantitative Structure-Activity Relationships (QSAR) Studies of Morita-Baylis-Hillman Adducts.
Lima- CG; Faheina-Martins GV; Bomfim CC; Dantas BB; Silva EP; Araújo DA; Filho EB; Vasconcellos ML
Med Chem; 2016; 12(7):602-612. PubMed ID: 27150963
[TBL] [Abstract][Full Text] [Related]
23. An efficient ultrasound-promoted synthesis of the Baylis-Hillman adducts catalyzed by imidazole and L-proline.
Mamaghani M; Dastmard S
Ultrason Sonochem; 2009 Apr; 16(4):445-7. PubMed ID: 19181559
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, and biological evaluation of thiophene analogues of chalcones.
Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Sarkar T; Hamel E
Bioorg Med Chem; 2008 May; 16(10):5367-76. PubMed ID: 18440234
[TBL] [Abstract][Full Text] [Related]
25. Asymmetric synthesis of anticancer beta-lactams via Staudinger reaction: utilization of chiral ketene from carbohydrate.
Banik BK; Banik I; Becker FF
Eur J Med Chem; 2010 Feb; 45(2):846-8. PubMed ID: 19962794
[TBL] [Abstract][Full Text] [Related]
26. Facile regio- and stereoselective metal-free synthesis of all-carbon tetrasubstituted alkenes bearing a C(sp3)-F unit via dehydroxyfluorination of Morita-Baylis-Hillman (MBH) adducts.
Takizawa S; Arteaga FA; Kishi K; Hirata S; Sasai H
Org Lett; 2014 Aug; 16(16):4162-5. PubMed ID: 25089369
[TBL] [Abstract][Full Text] [Related]
27. The total synthesis and biological properties of the cytotoxic macrolide FD-891 and its non-natural (Z)-C12 isomer.
García-Fortanet J; Murga J; Carda M; Marco JA; Matesanz R; Díaz JF; Barasoain I
Chemistry; 2007; 13(18):5060-74. PubMed ID: 17516610
[TBL] [Abstract][Full Text] [Related]
28. Kinetic resolution of hindered Morita-Baylis-Hillman adducts by Rh(I)-catalyzed asymmetric 1,4-addition/β-hydroxyelimination.
Wang Y; Feng X; Du H
Org Lett; 2011 Sep; 13(18):4954-7. PubMed ID: 21842895
[TBL] [Abstract][Full Text] [Related]
29. P(PhCH(2)NCH(2)CH(2))(3)N: an efficient lewis base catalyst for the synthesis of propargylic alcohols and Morita-Baylis-Hillman adducts via aldehyde alkynylation.
Wadhwa K; Chintareddy VR; Verkade JG
J Org Chem; 2009 Sep; 74(17):6681-90. PubMed ID: 19711995
[TBL] [Abstract][Full Text] [Related]
30. Preparation and biological evaluation of some 1,2-O-isopropylidene-D-hexofuranose esters.
Catelani G; D'Andrea F; Landi M; Zuccato C; Bianchi N; Gambari R
Carbohydr Res; 2006 Mar; 341(4):538-44. PubMed ID: 16413002
[TBL] [Abstract][Full Text] [Related]
31. Rhodium fluorapatite catalyst for the synthesis of trisubstituted olefins via cross coupling of Baylis-Hillman adducts and arylboronic acids.
Kantam ML; Kumar KB; Sreedhar B
J Org Chem; 2008 Jan; 73(1):320-2. PubMed ID: 18072787
[TBL] [Abstract][Full Text] [Related]
32. Asymmetric catalytic aza-Morita-Baylis-Hillman reaction (aza-MBH): an interesting functional group-caused reversal of asymmetric induction.
Shi M; Qi MJ; Liu XG
Chem Commun (Camb); 2008 Dec; (45):6025-7. PubMed ID: 19030574
[TBL] [Abstract][Full Text] [Related]
33. Hydroxyalkylation of conjugated nitroalkenes with activated nonenolizable carbonyl compounds.
Deb I; Dadwal M; Mobin SM; Namboothiri IN
Org Lett; 2006 Mar; 8(6):1201-4. PubMed ID: 16524303
[TBL] [Abstract][Full Text] [Related]
34. Chiral phosphine Lewis base catalyzed asymmetric aza-Baylis-Hillman reaction of N-sulfonated imines with methyl vinyl ketone and phenyl acrylate.
Shi M; Chen LH
Chem Commun (Camb); 2003 Jun; (11):1310-1. PubMed ID: 12809245
[TBL] [Abstract][Full Text] [Related]
35. Novel imidazole-based combretastatin A-4 analogues: evaluation of their in vitro antitumor activity and molecular modeling study of their binding to the colchicine site of tubulin.
Bellina F; Cauteruccio S; Monti S; Rossi R
Bioorg Med Chem Lett; 2006 Nov; 16(22):5757-62. PubMed ID: 16950621
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, anti-proliferative activity, theoretical and
Brito VBM; Santos GF; Silva TDS; Souza JLC; Militão GCG; Martins FT; Silva FPL; Oliveira BG; Araújo ECC; Vasconcellos MLAA; Lima-Júnior CG; Alencar-Filho EB
Mol Divers; 2020 Feb; 24(1):265-281. PubMed ID: 30955150
[TBL] [Abstract][Full Text] [Related]
37. N-Phenyl-N'-(2-chloroethyl)ureas (CEU) as potential antineoplastic agents. Part 2: role of omega-hydroxyl group in the covalent binding to beta-tubulin.
Fortin S; Moreau E; Patenaude A; Desjardins M; Lacroix J; Rousseau JL; C-Gaudreault R
Bioorg Med Chem; 2007 Feb; 15(3):1430-8. PubMed ID: 17118664
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, structure and anticancer activity of novel alkenyl-1,3,5-triazine derivatives.
Saczewski F; Bułakowska A
Eur J Med Chem; 2006 May; 41(5):611-5. PubMed ID: 16540207
[TBL] [Abstract][Full Text] [Related]
39. Recent extensions of the Morita-Baylis-Hillman reaction.
Ma GN; Jiang JJ; Shi M; Wei Y
Chem Commun (Camb); 2009 Oct; (37):5496-514. PubMed ID: 19753340
[TBL] [Abstract][Full Text] [Related]
40. Generation of ligand-based pharmacophore model and virtual screening for identification of novel tubulin inhibitors with potent anticancer activity.
Chiang YK; Kuo CC; Wu YS; Chen CT; Coumar MS; Wu JS; Hsieh HP; Chang CY; Jseng HY; Wu MH; Leou JS; Song JS; Chang JY; Lyu PC; Chao YS; Wu SY
J Med Chem; 2009 Jul; 52(14):4221-33. PubMed ID: 19507860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
